Article Text

PDF
Case series
Novel approaches to access and treatment of cavernous sinus dural arteriovenous fistula (CS-DAVF): case series and review of the literature
  1. Jason Wenderoth
  1. Correspondence to Dr Jason Wenderoth, Interventional Neuroradiology Department, Prince of Wales Hospital, Institute of Neurosciences, High Street, Randwick, Sydney, NSW 2031, Australia; jwenderoth{at}snis.com.au

Abstract

Caroticocavernous fistula or cavernous sinus dural arteriovenous fistula (CS-DAVF) has presented various treatment challenges over many years. This paper outlines these challenges in a review of the literature, and attempts to address them by analyzing the anatomical and hemodynamic characteristics of 32 consecutive patients with CS-DAVF treated between 2007 and 2016, in doing so proposing novel strategies for safe access and treatment of CS-DAVF.

Statistics from Altmetric.com

Footnotes

  • Contributors The author is the sole contributor to the compilation of the submission. Dr Andrew Cheung assisted in the care of three patients in the series.

  • Competing interests The author has paid consulting agreements with Medtronic, Irvine, California, USA and Microvention, Tustin, California, USA. The author is a stockholder in Medtronic, Irvine, California, USA and Stryker, California, USA

  • Ethics approval Ethics approval was obtained from the South Eastern Sydney Local Health District Human Research Ethics Committee.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles